Piper Sandler Maintains Overweight on InspireMD, Raises Price Target to $4.5
BenzingaNov 2, 2023 15:58 ET
InspireMD Analyst Ratings
BenzingaNov 2, 2023 15:56 ET
Piper Sandler Remains a Buy on InspireMD (NSPR)
TipRanksSep 25, 2023 06:55 ET
Alliance Global Adjusts Price Target on InspireMD to $4.75 From $5.15, Maintains Buy Rating
MT NewswiresMay 17, 2023 10:09 ET
National Alliance Securities Maintains Buy on InspireMD, Lowers Price Target to $4.75
BenzingaMay 17, 2023 09:52 ET
Alliance Global Partners Maintains Buy on InspireMD, Lowers Price Target to $5.15
BenzingaMar 31, 2023 13:06 ET
No Data
No Data